User talk:Plasmalipids

Welcome to Wikipedia from the Medicine WikiProject!


Welcome to Wikipedia from WikiProject Medicine (also known as WPMED). We're a group of editors who strive to improve the quality of medical articles here on Wikipedia. One of our members has noticed that you are interested in editing medical articles; it's great to have a new interested editor on board. In your wiki-voyages, a few things that may be relevant to editing Wikipedia articles are:


 * Thanks for coming aboard! We always appreciate a new editor. Feel free to leave us a message at any time on our talk page. If you are interested in joining the project yourself, there is a participant list where you can sign up. Please leave a message on the WPMED talk page if you have any problems, suggestions, would like review of an article, need suggestions for articles to edit, or would like some collaboration when editing!
 * Sourcing of medical and health-related content on Wikipedia is guided by our medical sourcing guidelines, commonly referred to as MEDRS. These guidelines typically require recent secondary sources to support information; their application is further explained here. Primary sources (case studies, case reports, research studies) are rarely used, especially if the primary sources are produced by the organisation or individual who is promoting a claim.
 * The Wikipedia community includes a wide variety of editors with different interests, skills, and knowledge. We all manage to get along through a lot of discussion that happens under the scenes and through the bold, revert, discuss editing cycle. If you encounter any problems, you can discuss them on an article's talk page or post a message on the WPMED talk page.

Feel free to drop a note on my talk page if you have any problems. I wish you all the best on your wiki voyages! Zefr (talk) 03:00, 4 November 2018 (UTC)

Managing a conflict of interest
Hello, Plasmalipids. We welcome your contributions, but if you have an external relationship with the people, places or things you have written about in the page Pterostilbene, you may have a conflict of interest (COI). Editors with a COI may be unduly influenced by their connection to the topic. See the conflict of interest guideline and FAQ for organizations for more information. We ask that you:


 * avoid editing or creating articles about yourself, your family, friends, company, organization or competitors;
 * propose changes on the talk pages of affected articles (see the request edit template);
 * disclose your COI when discussing affected articles (see WP:DISCLOSE);
 * avoid linking to your organization's website in other articles (see WP:SPAM);
 * do your best to comply with Wikipedia's content policies.

In addition, you must disclose your employer, client, and affiliation with respect to any contribution which forms all or part of work for which you receive, or expect to receive, compensation (see WP:PAID).

Also please note that editing for the purpose of advertising, publicising, or promoting anyone or anything is not permitted. ''If you have an interest in Elysium Health, you must declare it, and it would be best to avoid editing articles on compounds used in Elysium's products. '' Zefr (talk) 03:07, 4 November 2018 (UTC)

Pterostilbene edits
Hello. On my Talk page you said: "I am a lipid biochemist trying to edit Pterostilbene on the basis of two randomized, placebo-controlled trials. The first one showed that pterostilbene alone at 100 mg and 250 mg/day elevate LDL-C. First author was Riche. The second one showed that pterostilbene plus nicotinamide riboside elevates LDL-C. First author was Dellinger. Consistent with MEDRS, there are two secondary sources that analyzed Riche and Dellinger. One is a peer reviewed letter to the editor in Clinical Nutrition. The other is a news article in Nutritional Outlook. Two independent randomized, placebo-controlled trials and a peer reviewed article summarizing them. Seems to me, this is the evidence basis one would look for on wiki."
 * This article is a study on low numbers of people (20 per group) using doses unlikely to occur in foods or even in common supplements (100-250 mg per day), with publication in a marginal journal with a low impact factor. Overall, it impresses as weak, primary research not worth discussing in an encyclopedia. The second study PMID 29184669, also with low numbers of subjects and high, uncommon doses, doesn't allow any interpretation about pterostilbene, since the treatment was in combination with NAR. As shown in this PubMed search, there are no pterostilbene reviews published in high-quality clinical journals where effects on humans would be rigorously assessed; see WP:MEDASSESS for a description of the source quality expected for medical topics in the encyclopedia, even in their research sections. Following you here if you wish to respond. Best wishes in your editing. --Zefr (talk) 01:11, 5 November 2018 (UTC)